Legislation


SB 5020 – Washington

Status: Inactive / Dead
Year Introduced: 2021
Link: https://app.leg.wa.gov/billsummary?BillNumber=5020&Year=2021&Initiative=false

Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents. Requires the Health Care Authority to assess a penalty against a drug manufacturer on revenue generated from a price increase on a prescription drug that is not supported by clinical evidence; prohibits manufacturers from withdrawing a drug from the market to avoid paying the penalty.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found